Abstract
Preterm infants are at an increased risk of morbidity and mortality from vaccine-preventable diseases. Despite this, delays in routine immunization of preterm infants are common. Available guidelines clearly state that they should be immunized according to chronological age, irrespective of gestational age and birth weight or current weight. In this article, we try to assuage parental and provider doubts by reviewing data about immunogenicity, safety, and responses to routine immunizations in preterm infants with and without comorbidities. We also look at evidence for other strategies to help protect this fragile population. [Pediatr Ann. 2018;47(4):e147–e153.]
- 1.Centers for Disease Control and Prevention. Preterm birth. https://www.cdc.gov/reproductivehealth/maternalinfanthealth/pretermbirth.htm. Accessed April 2, 2018. Google Scholar
- 2.Langkamp DL, Davis JP. Increased risk of reported pertussis and hospitalization associated with pertussis in low birth weight children. J Pediatr. 1996; 128(5 Pt 1):654–659.
10.1016/S0022-3476(96)80131-4 Crossref Medline, Google Scholar - 3.Davis RL, Rubanowice D, Shinefield HR, Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization status. Centers for Disease Control and Prevention Vaccine Safety Datalink Group. JAMA. 1999; 282(6):547–553.
10.1001/jama.282.6.547 Crossref Medline, Google Scholar - 4.Bonhoeffer J, Siegrist CA, Heath PT. Immunisation of premature infants. Arch Dis Child. 2006; 91(11):929–935. doi:.
10.1136/adc.2005.086306 Crossref Medline, Google Scholar - 5.Gagneur A, Pinquier D, Quach C. Immunization of preterm infants. Hum Vaccin Immunother. 2015; 11(11):2556–2563. doi: .
10.1080/21645515.2015.1074358 Crossref Medline, Google Scholar - 6.Slack MH, Schapira D, Thwaites RJ, Responses to a fourth dose of Haemophilus influenzae type B conjugate vaccine in early life. Arch Dis Child Fetal Neonatal Ed. 2004; 89(3):F269–F271. doi:.
10.1136/adc.2003.030718 Crossref Medline, Google Scholar - 7.D'Angio CT, Maniscalco WM, Pichichero ME. Immunologic response of extremely premature infants to tetanus, Haemophilus influenzae, and polio immunizations. Pediatrics. 1995; 96(1 Pt 1):18–22. Crossref Medline, Google Scholar
- 8.Slack MH, Schapira D, Thwaites RJ, Acellular pertussis vaccine given by accelerated schedule: response of preterm infants. Arch Dis Child Fetal Neonatal Ed. 2004; 89(1):F57–F60.
10.1136/fn.89.1.F57 Crossref Medline, Google Scholar - 9.Vazquez L, Garcia F, Ruttimann R, Coconier G, Jacquet JM, Schuerman L. Immunogenicity and reactogenicity of DTPa-HBV-IPV/Hib vaccine as primary and booster vaccination in low-birth-weight premature infants. Acta Paediatr. 2008; 97(9):1243–1249. doi:.
10.1111/j.1651-2227.2008.00884.x Crossref Medline, Google Scholar - 10.Faldella G, Alessandroni R, Magini GM, The preterm infant's antibody response to a combined diphtheria, tetanus, acellular pertussis and hepatitis B vaccine. Vaccine. 1998; 16(17):1646–1649.
10.1016/S0264-410X(98)00060-7 Crossref Medline, Google Scholar - 11.Riise OR, Laake I, Vestrheim D, Risk of pertussis in relation to degree of prematurity in children less than 2 years of age. Pediatr Infect Dis J. 2017; 36(5):e151–e156. doi:.
10.1097/INF.0000000000001545 Crossref Medline, Google Scholar - 12.Schloesser RL, Fischer D, Otto W, Rettwitz-Volk W, Herden P, Zielen S. Safety and immunogenicity of an acellular pertussis vaccine in premature infants. Pediatrics. 1999; 103(5):e60.
10.1542/peds.103.5.e60 Crossref Medline, Google Scholar - 13.Omenaca F, Garcia-Sicilia J, Garcia-Corbeira P, Response of preterm newborns to immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio and Haemophilus influenzae type b vaccine: first experiences and solutions to a serious and sensitive issue. Pediatrics. 2005; 116(6):1292–1298. doi:.
10.1542/peds.2004-2336 Crossref Medline, Google Scholar - 14.Vermeulen F, Verscheure V, Damis E, Cellular immune responses of preterm infants after vaccination with whole-cell or acellular pertussis vaccines. Clin Vaccine Immunol. 2010; 17(2):258–262. doi:.
10.1128/CVI.00328-09 Crossref Medline, Google Scholar - 15.Crawford NW, Buttery JP. Preterm infants immunization. Paediatr Child Health. 2010; 20(6):297–301. doi:.
10.1016/j.paed.2010.02.011 Crossref, Google Scholar - 16.Adenyi-Jones SC, Faden H, Ferdon MB, Kwong MS, Ogra PL. Systemic and local immune responses to enhanced-potency inactivated poliovirus vaccine in premature and term infants. J Pediatr. 1992; 120(5):686–689.
10.1016/S0022-3476(05)80228-8 Crossref Medline, Google Scholar - 17.Slack MH, Cade S, Schapira D, DT5aP-Hib-IPV and MCC vaccines: preterm infants' response to accelerated immunisation. Arch Dis Child. 2005; 90(4):338–341. doi:.
10.1136/adc.2004.052720 Crossref Medline, Google Scholar - 18.Kirmani KI, Lofthus G, Pichichero ME, Voloshen T, D'Angio CT. Seven-year follow-up of vaccine response in extremely premature infants. Pediatrics. 2002; 109(3):498–504.
10.1542/peds.109.3.498 Crossref Medline, Google Scholar - 19.Berrington JE, Cant AJ, Matthews JN, O'Keeffe M, Spickett GP, Fenton AC. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose. Pediatrics. 2006; 117(4):e717–724. doi:.
10.1542/peds.2005-0348 Crossref Medline, Google Scholar - 20.Heath PT, Booy R, Griffiths H, Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. Clin Infect Dis. 2000; 31(4):973–980. doi:.
10.1086/318132 Crossref Medline, Google Scholar - 21.Ruggeberg JU, Collins C, Clarke P, Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants. Vaccine. 2006; 25(2):264–271. doi:.
10.1016/j.vaccine.2006.07.036 Crossref Medline, Google Scholar - 22.Omenaca F, Merino JM, Tejedor JC, Immunization of preterm infants with 10-valent pneumococcal conjugate vaccine. Pediatrics. 2011; 128(2):e290–298. doi:.
10.1542/peds.2010-1184 Crossref Medline, Google Scholar - 23.Martinon-Torres F, Czajka H, Center KJ, 13-valent pneumococcal conjugate vaccine (PCV13) in preterm versus term infants. Pediatrics. 2015; 135(4):e876–886. doi:.
10.1542/peds.2014-2941 Crossref Medline, Google Scholar - 24.American Academy of Pediatrics. Hepatitis B. In: , eds. Red Book: 2015 Report of the Committee on Infectious Diseases. Itasca, IL: American Academy of Pediatrics; 2015:191–192 Google Scholar
- 25.Freitas da Motta MS, Mussi-Pinhata MM, Jorge SM, Tachibana Yoshida CF, Sandoval de Souza CB. Immunogenicity of hepatitis B vaccine in preterm and full term infants vaccinated within the first week of life. Vaccine. 2002; 20(11–12):1557–1562.
10.1016/S0264-410X(01)00493-5 Crossref Medline, Google Scholar - 26.Lau YL, Tam AY, Ng KW, Response of preterm infants to hepatitis B vaccine. J Pediatr. 1992; 121(6):962–965.
10.1016/S0022-3476(05)80352-X Crossref Medline, Google Scholar - 27.Losonsky GA, Wasserman SS, Stephens I, Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization. Pediatrics. 1999; 103(2):E14.
10.1542/peds.103.2.e14 Crossref Medline, Google Scholar - 28.Kim SC, Chung EK, Hodinka RL, Immunogenicity of hepatitis B vaccine in preterm infants. Pediatrics. 1997; 99(4):534–536.
10.1542/peds.99.4.534 Crossref Medline, Google Scholar - 29.Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ. 2010; 340:c1626.
10.1136/bmj.c1626 Crossref Medline, Google Scholar - 30.Gans HA, Yasukawa LL, Alderson A, Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States. J Infect Dis. 2004; 190(1):83–90. doi:.
10.1086/421032 Crossref Medline, Google Scholar - 31.Eggertson L. Lancet retracts 12-year-old article linking autism to MMR vaccines. CMAJ. 2010; 182(4):E199–2E00. doi:.
10.1503/cmaj.109-3179 Crossref Medline, Google Scholar - 32.American Academy of Pediatrics. Measles. In: , eds. Red Book: 2015 Report of the Committee on Infectious Diseases. Itasca, IL: American Academy of Pediatrics; 2015:535–547. Google Scholar
- 33.D'Angio CT, Boohene PA, Mowrer A, Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants. Pediatrics. 2007; 119(3):e574–e579. doi:.
10.1542/peds.2006-2241 Crossref Medline, Google Scholar - 34.Marin M, Broder KR, Temte JL, Snider DE, Seward JFCenters for Disease Control and Prevention (CDC). Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010; 59(RR-3):1–12. Medline, Google Scholar
- 35.Omenaca F, Sarlangue J, Szenborn L, Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study. Pediatr Infect Dis J. 2012; 31(5):487–493. doi:.
10.1097/INF.0b013e3182490a2c Crossref Medline, Google Scholar - 36.Roue JM, Nowak E, Le Gal G, Impact of rotavirus vaccine on premature infants. Clin Vaccine Immunol. 2014; 21(10):1404–1409. doi:.
10.1128/CVI.00265-14 Crossref Medline, Google Scholar - 37.Ellison VJ, Davis PG, Doyle LW. Adverse reactions to immunization with newer vaccines in the very preterm infant. J Paediatr Child Health. 2005; 41(8):441–443. doi:.
10.1111/j.1440-1754.2005.00663.x Crossref Medline, Google Scholar - 38.Carbone T, McEntire B, Kissin D, Absence of an increase in cardiorespiratory events after diphtheria-tetanus-acellular pertussis immunization in preterm infants: a randomized, multicenter study. Pediatrics. 2008; 121(5):e1085–e1090. doi:.
10.1542/peds.2007-2059 Crossref Medline, Google Scholar - 39.Zaman K, Roy E, Arifeen SE, Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008; 359(15):1555–1564. doi:.
10.1056/NEJMoa0708630 Crossref Medline, Google Scholar - 40.Fell DB, Bhutta ZA, Hutcheon JA, Report of the WHO technical consultation on the effect of maternal influenza and influenza vaccination on the developing fetus: Montreal, Canada, September 30–October 1, 2015. Vaccine. 2017; 35(18):2279–2287. doi:.
10.1016/j.vaccine.2017.03.056 Crossref Medline, Google Scholar - 41.Groothuis JR, Levin MJ, Lehr MV, Weston JA, Hayward AR. Immune response to split-product influenza vaccine in preterm and full-term young children. Vaccine. 1992; 10(4):221–225.
10.1016/0264-410X(92)90156-E Crossref Medline, Google Scholar - 42.Wegzyn C, Toh LK, Notario G, Safety and effectiveness of palivizumab in children at high risk of serious disease due to respiratory syncytial virus infection: a systematic review. Infect Dis Ther. 2014; 3(2):133–158. doi:.
10.1007/s40121-014-0046-6 Crossref Medline, Google Scholar - 43.Hussman JM, Li A, Paes B, Lanctot KL. A review of cost-effectiveness of palivizumab for respiratory syncytial virus. Expert Rev Pharmacoecon Outcomes Res. 2012; 12(5):553–567. doi:.
10.1586/erp.12.45 Crossref Medline, Google Scholar - 44.Robinson MJ, Heal C, Gardener E, Powell P, Sims DG. Antibody response to diphtheria-tetanus-pertussis immunization in preterm infants who receive dexamethasone for chronic lung disease. Pediatrics. 2004; 113(4):733–737.
10.1542/peds.113.4.733 Crossref Medline, Google Scholar - 45.American Academy of Pediatrics. Immunization in immunocompromised children. In: , eds. Red Book: 2015 Report of the Committee on Infectious Diseases. Itasca, IL: American Academy of Pediatrics; 2015:74–89. Google Scholar
- 46.DeMeo SD, Raman SR, Hornik CP, Wilson CC, Clark R, Smith PB. Adverse events after routine immunization of extremely low-birth-weight infants. JAMA Pediatr. 2015; 169(8):740–745. doi:.
10.1001/jamapediatrics.2015.0418 Crossref Medline, Google Scholar - 47.Nunes MC, Aqil AR, Omer SB, Madhi SA. The effects of influenza vaccination during pregnancy on birth outcomes: a systematic review and meta-analysis. Am J Perinatol. 2016; 33(11):1104–1114. doi:.
10.1055/s-0036-1586101 Crossref Medline, Google Scholar
